In addition, (n = 7) women who previously used GnRH agonist (e.g., Lupron) therapy were 3.9 times more likely to have subsequent treatment for fibroids compared to (n = 123) women who never used GnRH agonist (p = 0.013). Here, GNRH1 is linked to leiomyoma.